SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-16-078078
Filing Date
2016-08-29
Accepted
2016-08-29 17:25:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 BIOTIME SC 13DA NO1 8-25-2016 (ONCOCYTE) formsc13da.htm SC 13D/A 59548
2 EXHIBIT 1 ex99.htm EX-99 26685
  Complete submission text file 0001140361-16-078078.txt   87799
Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502 5105213390
BIOTIME INC (Filed by) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502 510-521-3390
OncoCyte Corp (Subject) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89221 | Film No.: 161858746
SIC: 2835 In Vitro & In Vivo Diagnostic Substances